Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells

The French mouse clinic (Institut Clinique de la Souris; ICS) has produced more than 2000 targeting vectors for ‘à la carte’ mutagenesis in C57BL/6N mice. Although most of the vectors were used successfully for homologous recombination in murine embryonic stem cells (ESCs), a few have failed to targ...

Full description

Bibliographic Details
Main Authors: Valérie Erbs, Romain Lorentz, Benjamin Eisenman, Laurence Schaeffer, Laurence Luppi, Loic Lindner, Yann Hérault, Guillaume Pavlovic, Marie Wattenhofer-Donzé, Marie-Christine Birling
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/14/2/401
_version_ 1797620837667307520
author Valérie Erbs
Romain Lorentz
Benjamin Eisenman
Laurence Schaeffer
Laurence Luppi
Loic Lindner
Yann Hérault
Guillaume Pavlovic
Marie Wattenhofer-Donzé
Marie-Christine Birling
author_facet Valérie Erbs
Romain Lorentz
Benjamin Eisenman
Laurence Schaeffer
Laurence Luppi
Loic Lindner
Yann Hérault
Guillaume Pavlovic
Marie Wattenhofer-Donzé
Marie-Christine Birling
author_sort Valérie Erbs
collection DOAJ
description The French mouse clinic (Institut Clinique de la Souris; ICS) has produced more than 2000 targeting vectors for ‘à la carte’ mutagenesis in C57BL/6N mice. Although most of the vectors were used successfully for homologous recombination in murine embryonic stem cells (ESCs), a few have failed to target a specific locus after several attempts. We show here that co-electroporation of a CRISPR plasmid with the same targeting construct as the one that failed previously allows the systematic achievement of positive clones. A careful validation of these clones is, however, necessary as a significant number of clones (but not all) show a concatemerization of the targeting plasmid at the locus. A detailed Southern blot analysis permitted characterization of the nature of these events as standard long-range 5′ and 3′ PCRs were not able to distinguish between correct and incorrect alleles. We show that a simple and inexpensive PCR performed prior to ESC amplification allows detection and elimination of those clones with concatemers. Finally, although we only tested murine ESCs, our results highlight the risk of mis-validation of any genetically modified cell line (such as established lines, induced pluripotent stem cells or those used for ex vivo gene therapy) that combines the use of CRISPR/Cas9 and a circular double-stranded donor. We strongly advise the CRISPR community to perform a Southern blot with internal probes when using CRISPR to enhance homologous recombination in any cell type, including fertilized oocytes.
first_indexed 2024-03-11T08:47:17Z
format Article
id doaj.art-c7f412b873e24e81a40e073edcd96636
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-11T08:47:17Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-c7f412b873e24e81a40e073edcd966362023-11-16T20:42:28ZengMDPI AGGenes2073-44252023-02-0114240110.3390/genes14020401Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES CellsValérie Erbs0Romain Lorentz1Benjamin Eisenman2Laurence Schaeffer3Laurence Luppi4Loic Lindner5Yann Hérault6Guillaume Pavlovic7Marie Wattenhofer-Donzé8Marie-Christine Birling9CNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceCNRS, INSERM, Université de Strasbourg, CELPHEDIA, PHENOMIN-Institut Clinique de la Souris (ICS), 1 rue Laurent Fries, 67404 Illkirch Graffenstaden, FranceThe French mouse clinic (Institut Clinique de la Souris; ICS) has produced more than 2000 targeting vectors for ‘à la carte’ mutagenesis in C57BL/6N mice. Although most of the vectors were used successfully for homologous recombination in murine embryonic stem cells (ESCs), a few have failed to target a specific locus after several attempts. We show here that co-electroporation of a CRISPR plasmid with the same targeting construct as the one that failed previously allows the systematic achievement of positive clones. A careful validation of these clones is, however, necessary as a significant number of clones (but not all) show a concatemerization of the targeting plasmid at the locus. A detailed Southern blot analysis permitted characterization of the nature of these events as standard long-range 5′ and 3′ PCRs were not able to distinguish between correct and incorrect alleles. We show that a simple and inexpensive PCR performed prior to ESC amplification allows detection and elimination of those clones with concatemers. Finally, although we only tested murine ESCs, our results highlight the risk of mis-validation of any genetically modified cell line (such as established lines, induced pluripotent stem cells or those used for ex vivo gene therapy) that combines the use of CRISPR/Cas9 and a circular double-stranded donor. We strongly advise the CRISPR community to perform a Southern blot with internal probes when using CRISPR to enhance homologous recombination in any cell type, including fertilized oocytes.https://www.mdpi.com/2073-4425/14/2/401gene targetingdouble-strand breakembryonic stem cellsgenome editingCRISPR/Cas9homologous recombination
spellingShingle Valérie Erbs
Romain Lorentz
Benjamin Eisenman
Laurence Schaeffer
Laurence Luppi
Loic Lindner
Yann Hérault
Guillaume Pavlovic
Marie Wattenhofer-Donzé
Marie-Christine Birling
Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells
Genes
gene targeting
double-strand break
embryonic stem cells
genome editing
CRISPR/Cas9
homologous recombination
title Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells
title_full Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells
title_fullStr Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells
title_full_unstemmed Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells
title_short Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells
title_sort increased on target rate and risk of concatemerization after crispr enhanced targeting in es cells
topic gene targeting
double-strand break
embryonic stem cells
genome editing
CRISPR/Cas9
homologous recombination
url https://www.mdpi.com/2073-4425/14/2/401
work_keys_str_mv AT valerieerbs increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT romainlorentz increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT benjamineisenman increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT laurenceschaeffer increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT laurenceluppi increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT loiclindner increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT yannherault increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT guillaumepavlovic increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT mariewattenhoferdonze increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells
AT mariechristinebirling increasedontargetrateandriskofconcatemerizationaftercrisprenhancedtargetinginescells